Impact of insurance status on radiation treatment modality selection among potential candidates for prostate, breast, or gynecologic brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 93, Issue 5, 2015, Pages 968-975

  Grant, Stephen R ^a   Walker, Gary V ^b   Koshy, Matthew ^c   Shaitelman, Simona F ^b   Klopp, Ann H ^b   Frank, Steven J ^b   Pugh, Thomas J ^b   Allen, Pamela K ^b   Mahmood, Usama ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS; DISEASES; HEALTH INSURANCE; LOGISTIC REGRESSION; ONCOLOGY; PATIENT MONITORING; UROLOGY;

CONFIDENCE INTERVAL; COST EFFECTIVE TREATMENTS; GYNECOLOGIC BRACHYTHERAPY; INSURANCE COVERAGES; METHODS AND MATERIALS; MULTIVARIATE LOGISTIC REGRESSIONS; RADIATION TREATMENTS; TREATMENT TECHNIQUES;

RADIOTHERAPY;

ADULT; BRACHYTHERAPY; BREAST CANCER; CANCER RADIOTHERAPY; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HEALTH CARE POLICY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MIDDLE AGED; PRIORITY JOURNAL; PROSTATE CANCER; TREATMENT OUTCOME; UTERINE CERVIX CANCER; AGED; BREAST NEOPLASMS; CANCER REGISTRY; CONFIDENCE INTERVAL; ENDOMETRIAL NEOPLASMS; HEALTH INSURANCE; INSURANCE; MEDICALLY UNINSURED; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTERINE CERVICAL NEOPLASMS; UTILIZATION; YOUNG ADULT;

ADULT; AGED; BRACHYTHERAPY; BREAST NEOPLASMS; CONFIDENCE INTERVALS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; INSURANCE COVERAGE; INSURANCE, HEALTH; MALE; MEDICAID; MEDICALLY UNINSURED; MIDDLE AGED; PATIENT PROTECTION AND AFFORDABLE CARE ACT; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; SEER PROGRAM; UNITED STATES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84946761407     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2015.08.036     Document Type: Conference Paper

References (28)

1. S.R. Grant, G.V. Walker, B.A. Guadagnolo, and et al. Variation in insurance status by patient demographics and tumor site among nonelderly adult patients with cancer Cancer 121 2015 2020 2028
2. G.V. Walker, S.R. Grant, B.A. Guadagnolo, and et al. Disparities in stage at diagnosis, treatment, and survival in nonelderly adult patients with cancer according to insurance status J Clin Oncol 32 2014 3118 3125
3. Congress of the United States Congressional Budget Office. Updated Estimates of the Effects of the Insurance Coverage Provisions of the Affordable Care Act. 2014. Available from: http://www.cbo.gov/sites/default/files/45231-ACA-Estimates.pdf. Accessed May 28, 2015.
4. National Comprehensive Cancer Network. Breast Cancer (Version 2.2015). Available from: http://www.nccn.org/professionals/physician-gls/pdf/breast.pdf. Accessed May 28, 2015.
5. National Comprehensive Cancer Network. Cervical Cancer (Version 2.2015). Available from: http://www.nccn.org/professionals/physician-gls/pdf/cervical.pdf. Accessed May 28, 2015.
6. National Comprehensive Cancer Network. Prostate Cancer (Version 1.2015). Available from: http://www.nccn.org/professionals/physician-gls/pdf/prostate.pdf. Accessed May 28, 2015.
7. National Comprehensive Cancer Network. Uterine Neoplasms (Version 2.2015). Available from: http://www.nccn.org/professionals/physician-gls/pdf/uterine.pdf. Accessed May 28, 2015.
8. P.L. Nguyen, X. Gu, S.R. Lipsitz, and et al. Cost implications of the rapid adoption of newer technologies for treating prostate cancer J Clin Oncol 29 2011 1517 1524
9. A. Eldefrawy, D. Katkoori, M. Abramowitz, and et al. Active surveillance vs. treatment for low-risk prostate cancer: A cost comparison Urol Oncol 31 2013 576 580
10. D.G. Petereit, S.J. Frank, A.N. Viswanathan, and et al. Brachytherapy: Where has it gone? J Clin Oncol 33 2015 980 982
11. J.M. Martin, E.A. Handorf, A. Kutikov, and et al. The rise and fall of prostate brachytherapy: Use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base Cancer 120 2014 2114 2121
12. U. Mahmood, T. Pugh, S. Frank, and et al. Declining use of brachytherapy for the treatment of prostate cancer Brachytherapy 13 2014 157 162
13. K. Han, M. Milosevic, A. Fyles, and et al. Trends in the utilization of brachytherapy in cervical cancer in the United States Int J Radiat Oncol Biol Phys 87 2013 111 119
14. B.S. Gill, J.F. Lin, T.C. Krivak, and et al. National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: The impact of new technological advancements Int J Radiat Oncol Biol Phys 90 2014 1083 1090
15. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER∗Stat Database: Incidence - SEER 18 Regs Research Data, Nov 2012 Sub (1973-2010) - Linked To County Attributes - Total U.S., 1969-2010 Counties. National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch.
16. Surveillance, Epidemiology, and End Results Program. County Attributes. Available from: http://seer.cancer.gov/seerstat/variables/countyattribs/. Accessed November 21, 2013.
17. P.J. Eifel, A. Ho, N. Khalid, and et al. Patterns of radiation therapy practice for patients treated for intact cervical cancer in 2005 to 2007: A quality research in radiation oncology study Int J Radiat Oncol Biol Phys 89 2014 249 256
18. C. Shah, T.B. Lanni Jr., M.I. Ghilezan, and et al. Brachytherapy provides comparable outcomes and improved cost-effectiveness in the treatment of low/intermediate prostate cancer Brachytherapy 11 2012 441 445
19. R.W. Naumann The role of radiation therapy in early endometrial cancer Curr Opin Obstet Gynecol 14 2002 75 79
20. D.N. Sharma, S.V. Deo, G.K. Rath, and et al. Perioperative high-dose-rate interstitial brachytherapy boost for patients with early breast cancer Tumori 99 2013 604 606
21. R.A. Nout, H. Putter, I.M. Jurgenliemk-Schulz, and et al. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: First results of the randomized PORTEC-2 trial J Clin Oncol 27 2009 3547 3556
22. D.J. Sher, E. Wittenberg, W.W. Suh, and et al. Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: A cost-effectiveness analysis Int J Radiat Oncol Biol Phys 74 2009 440 446
23. W.W. Suh, L.J. Pierce, F.A. Vicini, and et al. A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer Int J Radiat Oncol Biol Phys 62 2005 790 796
24. S.A. Fedewa, R. Etzioni, W.D. Flanders, and et al. Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004-2006 Cancer Epidemiol Biomarkers Prev 19 2010 2437 2444
25. S.A. Fedewa, V. Cokkinides, K.S. Virgo, and et al. Association of insurance status and age with cervical cancer stage at diagnosis: National Cancer Database, 2000-2007 Am J Public Health 102 2012 1782 1790
26. C. Schoen, M.M. Doty, R.H. Robertson, and et al. Affordable Care Act reforms could reduce the number of underinsured US adults by 70 percent Health Aff (Millwood) 30 2011 1762 1771
27. D. Blumenthal, and S.R. Collins Health care coverage under the Affordable Care Act-a progress report N Engl J Med 371 2014 275 281
28. B.N. Polite, J.J. Griggs, B. Moy, and et al. American Society of Clinical Oncology policy statement on Medicaid reform J Clin Oncol 32 2014 4162 4167